2012 Archive

May 3, 2012

Lin	The Brigham Renal Board Review Course (Part 3)    Boston, MA; August, 2011 Nephrology Board Review Cases Julie Lin, MD, MPH

Navar

American Society of Hypertension Annual Scientific Meeting (Part 10)    New York, NY; May, 2011 Intrarenal Renin Angiotensin System L. Gabriel Navar, PhD

McIntyre   Kooman   Blagg

Advances in CKD 2012 (Part 2)    Palm Harbor, FL; January, 2012 Endotoxinemia in progress of CKD: bystander or culprit? Chris McIntyre, MD Can physical and occupational rehabilitation make a difference to outcomes? S. Vanita Jassal, MD Renal replacement therapy in geriatric ESRD patients—a clinical approach Jeroen P. Kooman, MD, PhD What are the considerations for life decisions in ESRD? Christopher R. Blagg, MD, FRCP

April 3, 2012

Salant

The Brigham Renal Board Review Course (Part 2)    Boston, MA; August, 2011 Approach to the Diagnosis and Management of RPGN David J. Salant, MD

Molitch   Garvin

American Society of Hypertension Annual Scientific Meeting (Part 9)    New York, NY; May, 2011 Management of Metabolic Co-Morbidities Mark E. Molitch, M.D. NO, O2- and renal Na handling Jeffrey L. Garvin, MD

March 11, 2012

Robinson

The Brigham Renal Board Review Course (Part 1)    Boston, MA; August, 2011 Must-Know Board Zebras Emily Robinson, MD

Bushinsky   Ruilope

American Society of Hypertension Annual Scientific Meeting (Part 8)    New York, NY; May, 2011 HYPERKALEMIA Management of Chronic Hyperkalemia David A. Bushinsky, MD Use of RAAS Inhibitors for Cardio-Renal Risk Reduction and Potassium Management Luis M. Ruilope, MD

Misra   Joerres   Schaefer

Advances in CKD 2012 (Part 1)    Palm Harbor, FL; January, 2012 How to personalize the dialysis prescription Madhukar Misra, MD Novel PD solutions—what are the clinical implications? Aechim Joerres, MD Long-term care of the kidney transplant recipient Heidi M. Schaefer, MD

February 20, 2012

Bisognano   Garcia-Donaire   Krum   Schmieder

American Society of Hypertension Annual Scientific Meeting (Part 7)    New York, NY; May, 2011 SURGICAL ABLATION FOR REFRACTORY HTN Baroreflex Activation Therapy in Patients with Resistant Hypertension John D. Bisognano, MD, PhD True Resistant Hypertension José A. García-Donaire, MD, PhD Renal Denervation: How to Evaluate & Choose the Appropriate Patient Henry Krum MBBS, PhD Renal Nerve Ablation Roland E. Schmieder

Annual Dialysis Conference 2011 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2011) (4 talks) CARDIOVASCULAR ISSUES IN PD AND HD PAIENTS Cardiovascular Death in PD vs. HD Patients James Sloand, MD Coronary Stenting vs. By-Pass Surgery in the Treatment of CAD in Dialysis Population Kul Aggarwal, MD Cardiac Stunning in Center and Home Dialysis Brigitte Schiller, MD Update on Cardio-Renal Syndrome Kevin Dellsperger, MD

January 29, 2012

Harris   Panza   Touyz   Webb

American Society of Hypertension Annual Scientific Meeting (Part 6)    New York, NY; May, 2011 OFF-TARGET CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS Non-Steroidal Anti-Inflammatory Drugs Raymond C. Harris, MD PPAR Agents Julio A. Panza, MD Anti-VEGF and Other Chemotherapeutic Agents Rhian M. Touyz, MD, PhD PDE5 Inhibitors and Organic Nitrates David J. Webb, MD

Lester   Quesnelle   Sureshbabu   Shelkov

National Association of Nephrology Technicians/Technologists (NANT) (Part 3)    PART 3 Practical Approach to Infection Control Melinda Martin-Lester, RN, BA, CNN, CHC Green Dialysis for a Greener Tomorrow: Environmentally Conscious Hemodialysis Therapy Rejean Quesnelle, Renal Technologist Practical Infection Control Nisha Sureshbabu What's Wrong with This Picture? Diane Shelkov, CHT

Annual Dialysis Conference 2011 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2011) (3 talks) RESIDUAL RENAL FUNCTION Should Volume Overloaded Dialysis Patients Be Aggressively Ultrafiltered to “Dry Weight” Even if Residual Renal Function Declines? Thomas Golper, MD Residual Kidney Function is a Vital Tool to Improve Outcomes Bernard Canaud, MD How Can We Preserve RRF on Dialysis? Isaac Teitelbaum, MD

January 4, 2012

Drawz   Inrig   Ruilope   Zand

American Society of Hypertension Annual Scientific Meeting (Part 5)    New York, NY; May, 2011 HYPERTENSION IN CKD Cardiovascular Risk Assessment – Addition of CKD and Race to the Framingham Equation Paul E. Drawz, MD The Mechanisms and Treatment of Intradialytic Hypertension (MATCH) Study Jula K Inrig, MD Hypertension in Advanced Kidney Disease Luis M. Ruilope, MD Hypertension in Renal Transplant Patients Martin S. Zand, MD

Sweeny   Go

National Association of Nephrology Technicians/Technologists (NANT) (Part 2)    PART 2 Home Dialysis - Coming to a Home Near You! John Sweeny, BS, CHT Fluid Management - Looking Beyond "You're Gaining Too Much Fluid" Elaine Go, NP, MSN, CNN Patients and Machines John Sweeny, BS, CHT

Annual Dialysis Conference 2011 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2011) (5 talks) IMPROVING OUTCOMES BY TARGETING VOLUME STATUS IN PD Is Measuring the Bioimpedance the New Way of Improving Outcomes in PD? John Van Stone, MD Low Sodium Dialysis Solution in PD Simon Davies, MD Low Sodium Intake Should Not Be Advised in PD Patients Martin Schreiber, MD Low Sodium Intake Should Be Advised in Most PD Patients Simon Davies, MD Update on Aquaporins Raymond Krediet, MD

December 1, 2011

Colussi   Lowenstein   Luther   Mori

American Society of Hypertension Annual Scientific Meeting (Part 4)    New York, NY; May, 2011 ALDOSTERONE Plasma Aldosterone Levels Affect Calcium Metabolism in Patients with Essential Hypertension Gian Luca Colussi, Cristiana Catena, Leonardo A. Sechi, L Marzano Interactions Between Aldosterone and Nitric Oxide Charles J. Lowenstein, MD Non-Renal Effects of Aldosterone James M. Luther, MD Inappropriately Intense Salt Restriction Augmenting Myocardial Fibrosis in an Animal Model Tatsuhiko Mori, Kenichi Hasegawa, Matsuda Hirohisa, Yasuo Matsumura, Nobukazu Ishizaka

Scher   Sharma   Daugirdas

National Association of Nephrology Technicians/Technologists (NANT) (Part 1)    PART 1 ESRD Modalities Gary Scher Treatment Modalities Armit Sharma, MD Hemodialysis Adequacy John Daugirdas, MD

Annual Dialysis Conference 2011 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2011) (13 talks) IMPROVING CARDIOVASCULAR OUTCOMES ON DIALYSIS: WHAT IS KEY? Achieving Sodium Balance: Does Type of Dialysis Impact Outcome? Alan Kliger, MD HD Induced Cardiac Injury: What Do We Know? Georges Saab, MD Sudden Death on Dialysis: Can Fatal Arrhythmias Be Prevented? Martin Alpert, MD Impact of Cardioprotective Drugs (beta blockers and ACEI) on Cardiovascular Outcomes Christopher Chan, MD NURSING PLENARY SESSION: NAVIGATING NURSING QUALITY IN NEPHROLOGY Nursing Plenary Session: Navigating Nursing Quality in Nephrology Isis Montalvo, MBA, MS, RN PEDiATRIC NURSING KEYNOTE: LEADERSHIP OF THE SPIRIT Pediatric Nursing Keynote: Leadership of the Spirit Leah Curtin PhD, RN UPDATE ON HOME DIALYSIS Global Perspective on Home Dialysis Therapies Steven Guest, MD 8 Years Experience of a Home Dialysis Provider - Achievements and Opportunities Brigitte Schiller, MD Cost Comparison of In-Center HD and Home Dialysis Therapies in the USA. Is Bundling Going to Affect the Growth of Home Dialysis Fredric Finkelstein, MD Will Home HD Steal Patients from PD? Joanne Bargman, MD MANAGING INTRADIALYTIC HYPOTENSION (IDH): WHAT WORKS? The Role of Frequency and Time in Prevention of IDH John Daugirdas, MD How does Diastolic Dysfunction Impact IDH? Roberto Pecoits-Filho, MD Has HD Technology Helped To Reduce the Incidence of IDH? Andrew Davenport, MD

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?